Bullish Moving Averages
4
Bearish Moving Averages
7
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Open Price
1050.00Prev. Close
1031.8500Volume
5638.00Value
5945271.00Fundamentals
Market Cap Cr
4586.40
Price to Earnings
317.90
Price to Book Value
-69.50
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
3775.35
Net Profit TTM Cr
14.43
Cash From Operating Activity Cr
-45.32
Return on Equity %
0.00
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
18 May, 2024
59.2
Week
58.4
Month
60
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1052.77
PIVOT
First Resistance
1063.68
Second Resistance
1072.87
Third Resistance
1083.78
First Support
1043.58
Second Support
1032.67
Third Support
1023.48
Relative Strength Index
46.66
Money Flow Index
38.4
MACD
-15.03
MACD Signal
-6.54
Average True Range
44.84
Average Directional Index
23.88
Rate of Change (21)
-5.26
Rate of Change (125)
Commodity Channel Index
-62.6
Williams %R
-74.6
BETA
1 Month
0.63
3 Month
0.44
1 Year
3 Year
PRICE CHANGE ANALYSIS
↑ 0.71%
1 Week
Low
High
1002.85
1120.5
↓ -6.53%
1 Month
Low
High
1002.85
1225
↓ -8.38%
3 Months
Low
High
970
1225
↓ -16.18%
6 Months
Low
High
970
1258
↓ -16.18%
1 Year
Low
High
970
1258
15 May 2024
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended March 31, 2024
06 May 2024
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Acquisition
The Board of Directors of Entero Healthcare Solutions Limited ("Company") has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held on May 06, 2024.
06 May 2024
Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 06, 2024
The Board of Directors of Entero Healthcare Solutions Limited ('Company') has approved, inter-alia, to execute the definitive agreements to acquire 80% paid-up equity share capital of Avenir Lifecare Pharma Private Limited ('ALPPL') at their meeting held today i.e. 6th May 2024.
03 May 2024
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
03 May 2024
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
25 Apr 2024
Entero Healthcare Solutions Ltd - 544122 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyEntero Healthcare Solutions Ltd 2CIN NO.U74999HR2018PLC072204 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY INDBBB 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Jayant Prakash Designation: General Counsel Company Secretary and Compliance Officer EmailId: jayant.prakash@enterohealthcare.com Name of the Chief Financial Officer: venkataramana Ram Chebolu Designation: Chief Financial Officer EmailId: ram.cv@enterohealthcare.com Date: 25/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
24 Apr 2024
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
24 Apr 2024
Entero Healthcare Solutions Ltd - 544122 - Compliance Certificate In Terms Of Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Submission of Compliance certificate in terms of Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
15 Apr 2024
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
12 Apr 2024
Jefferies Initiates 'Buy' On Entero Healthcare, Stock Hits 20% Upper Limit
Jefferies estimates Entero to log a 44% revenue CAGR and an eight-times increase in adjusted profit after tax over FY2426.
